Net Change In Cash - Viridian Therapeutics Inc (NASDAQ:VRDN) - Alpha Spread

Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.5 USD 6.84% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Viridian Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
Net Change in Cash
$20.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
11%
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Viridian Therapeutics Inc's Net Change in Cash?
Net Change in Cash
20.6m USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's Net Change in Cash amounts to 20.6m USD.

What is Viridian Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
11%

Over the last year, the Net Change in Cash growth was -63%.

Back to Top